Tissue Regenix Group Investor Relations Material
Latest events
H2 2024
Tissue Regenix Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tissue Regenix Group plc
Access all reports
Tissue Regenix Group plc is a UK-based regenerative medical devices company. It develops and commercializes biological implants and tissue-based products for use in orthopedics, wound care, and dental applications. Its patented decellularization technology processes human and animal tissue for safe and effective transplant use. The company is headquartered in Leeds, United Kingdom, and its shares are listed on the LSE.
Key slides for Tissue Regenix Group plc
H2 2024
Tissue Regenix Group plc
H2 2024
Tissue Regenix Group plc
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
TRX
Country
🇬🇧 United Kingdom